Cargando…
High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). We retrospectively analyzed the efficacy of high-dose dexamethasone in patients with COVID-19-related ARDS and evaluated factors affecting the composite o...
Autores principales: | Vecchié, Alessandra, Batticciotto, Alberto, Tangianu, Flavio, Bonaventura, Aldo, Pennella, Benedetta, Abenante, Alessia, Corso, Rossana, Grazioli, Stefano, Mumoli, Nicola, Para, Ombretta, Maresca, Andrea Maria, Dalla Gasperina, Daniela, Dentali, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286167/ https://www.ncbi.nlm.nih.gov/pubmed/34275096 http://dx.doi.org/10.1007/s11739-021-02800-1 |
Ejemplares similares
-
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022) -
Correlation of SpO(2)/FiO(2) and PaO(2)/FiO(2) in patients with symptomatic COVID-19: An observational, retrospective study
por: Bonaventura, Aldo, et al.
Publicado: (2022) -
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
por: Potere, Nicola, et al.
Publicado: (2022) -
Lung Function and Symptoms in Post–COVID-19 Patients: A Single-Center Experience
por: Mumoli, Nicola, et al.
Publicado: (2021) -
Cardiac injury as prognostic value in COVID-19: more remains to be clarified
por: Mumoli, Nicola, et al.
Publicado: (2020)